Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

The bacterial communities of the small intestine and stool in children with short bowel syndrome.

Zeichner SL, Mongodin EF, Hittle L, Huang SH, Torres C.

PLoS One. 2019 May 16;14(5):e0215351. doi: 10.1371/journal.pone.0215351. eCollection 2019.

2.

RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Lin HC, Simon PJ, Ysla RM, Zeichner SL, Brewer G, Rabson AB.

Virology. 2017 Aug;508:7-17. doi: 10.1016/j.virol.2017.04.029. Epub 2017 May 4.

3.

Correction for Prasad et al., Activation of Human Herpesvirus Replication by Apoptosis.

Prasad A, Remick J, Zeichner SL.

J Virol. 2016 Jun 10;90(13):6171-6172. doi: 10.1128/JVI.00681-16. Print 2016 Jul 1. No abstract available.

4.

The Oral Bacterial Communities of Children with Well-Controlled HIV Infection and without HIV Infection.

Goldberg BE, Mongodin EF, Jones CE, Chung M, Fraser CM, Tate A, Zeichner SL.

PLoS One. 2015 Jul 6;10(7):e0131615. doi: 10.1371/journal.pone.0131615. eCollection 2015.

5.

Apoptosis-induced activation of HIV-1 in latently infected cell lines.

Khan SZ, Hand N, Zeichner SL.

Retrovirology. 2015 May 16;12:42. doi: 10.1186/s12977-015-0169-1.

6.

Culture-independent evaluation of the appendix and rectum microbiomes in children with and without appendicitis.

Jackson HT, Mongodin EF, Davenport KP, Fraser CM, Sandler AD, Zeichner SL.

PLoS One. 2014 Apr 23;9(4):e95414. doi: 10.1371/journal.pone.0095414. eCollection 2014.

7.

Activation of human herpesvirus replication by apoptosis.

Prasad A, Remick J, Zeichner SL.

J Virol. 2013 Oct;87(19):10641-50. doi: 10.1128/JVI.01178-13. Epub 2013 Jul 24. Erratum in: J Virol. 2016 Jun 10;90(13):6171-2.

8.

Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins.

Fernandez G, Zaikos TD, Khan SZ, Jacobi AM, Behlke MA, Zeichner SL.

J Virol. 2013 Apr;87(7):3966-78. doi: 10.1128/JVI.03251-12. Epub 2013 Jan 30.

9.

Twice-daily application of HIV microbicides alter the vaginal microbiota.

Ravel J, Gajer P, Fu L, Mauck CK, Koenig SS, Sakamoto J, Motsinger-Reif AA, Doncel GF, Zeichner SL.

MBio. 2012 Dec 18;3(6). pii: e00370-12. doi: 10.1128/mBio.00370-12.

10.

An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis.

Prasad A, Lu M, Lukac DM, Zeichner SL.

J Virol. 2012 Apr;86(8):4404-19. doi: 10.1128/JVI.06617-11. Epub 2012 Feb 15.

11.

Cell line-dependent variability in HIV activation employing DNMT inhibitors.

Fernandez G, Zeichner SL.

Virol J. 2010 Oct 13;7:266. doi: 10.1186/1743-422X-7-266.

12.

p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.

Cherrier T, Suzanne S, Redel L, Calao M, Marban C, Samah B, Mukerjee R, Schwartz C, Gras G, Sawaya BE, Zeichner SL, Aunis D, Van Lint C, Rohr O.

Oncogene. 2009 Sep 24;28(38):3380-9. doi: 10.1038/onc.2009.193. Epub 2009 Jul 6.

13.

Emergence of human immunodeficiency virus type 1 variants containing the Q151M complex in children receiving long-term antiretroviral chemotherapy.

Harada S, Hazra R, Tamiya S, Zeichner SL, Mitsuya H.

Antiviral Res. 2007 Aug;75(2):159-66. Epub 2007 Mar 21.

PMID:
17418430
14.

Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART).

Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L.

Dev Neuropsychol. 2006;30(2):633-57.

PMID:
16995830
15.

Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.

Gafni RI, Hazra R, Reynolds JC, Maldarelli F, Tullio AN, DeCarlo E, Worrell CJ, Flaherty JF, Yale K, Kearney BP, Zeichner SL.

Pediatrics. 2006 Sep;118(3):e711-8. Epub 2006 Aug 21.

PMID:
16923923
16.

Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection.

Hazra R, Gafni RI, Maldarelli F, Balis FM, Tullio AN, DeCarlo E, Worrell CJ, Steinberg SM, Flaherty J, Yale K, Kearney BP, Zeichner SL.

Pediatrics. 2005 Dec;116(6):e846-54. Epub 2005 Nov 15.

PMID:
16291735
17.
18.
19.

Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.

Lu M, Suen J, Frias C, Pfeiffer R, Tsai MH, Chuang E, Zeichner SL.

J Virol. 2004 Dec;78(24):13637-52.

21.

Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.

Hazra R, Balis FM, Tullio AN, DeCarlo E, Worrell CJ, Steinberg SM, Flaherty JF, Yale K, Poblenz M, Kearney BP, Zhong L, Coakley DF, Blanche S, Bresson JL, Zuckerman JA, Zeichner SL.

Antimicrob Agents Chemother. 2004 Jan;48(1):124-9.

22.
23.

Gene expressions in Jurkat cells poisoned by a sulphur mustard vesicant and the induction of apoptosis.

Zhang P, Ng P, Caridha D, Leach RA, Asher LV, Novak MJ, Smith WJ, Zeichner SL, Chiang PK.

Br J Pharmacol. 2002 Sep;137(2):245-52.

24.

Burkitt's/Burkitt's-like lymphoma presenting as bacterial sinusitis in two HIV-infected children.

Robinson MR, Salit RB, Bryant-Greenwood PK, Zeichner SL, Wood LV, Jaffe ES, van Waes C, Magrath IT.

AIDS Patient Care STDS. 2001 Sep;15(9):453-8.

PMID:
11587630
25.

Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation.

Ng PW, Iha H, Iwanaga Y, Bittner M, Chen Y, Jiang Y, Gooden G, Trent JM, Meltzer P, Jeang KT, Zeichner SL.

Oncogene. 2001 Jul 27;20(33):4484-96.

26.

Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.

Jankelevich S, Mueller BU, Mackall CL, Smith S, Zwerski S, Wood LV, Zeichner SL, Serchuck L, Steinberg SM, Nelson RP, Sleasman JW, Nguyen BY, Pizzo PA, Yarchoan R.

J Infect Dis. 2001 Apr 1;183(7):1116-20. Epub 2001 Mar 1.

PMID:
11237839
27.

Sino-orbital-cerebral aspergillosis in immunocompromised pediatric patients.

Robinson MR, Fine HF, Ross ML, Mont EK, Bryant-Greenwood PK, Hertle RW, Tisdale JF, Young NS, Zeichner SL, Van Waes C, Whitcup SM, Walsh TJ.

Pediatr Infect Dis J. 2000 Dec;19(12):1197-203. Review. No abstract available.

PMID:
11144384
28.

Telomere dynamics in monkeys: increased cell turnover in macaques infected with chimeric simian-human immunodeficiency viruses.

Shibata R, Feng YR, Gee D, Norwood D, Xiao X, Zeichner SL, Martin MA, Dimitrov DS.

J Med Primatol. 1999 Feb;28(1):1-10.

PMID:
10372535
29.

Rapid telomere shortening in children.

Zeichner SL, Palumbo P, Feng Y, Xiao X, Gee D, Sleasman J, Goodenow M, Biggar R, Dimitrov D.

Blood. 1999 May 1;93(9):2824-30.

30.

Telomere dynamics in HIV-1 infected and uninfected chimpanzees measured by an improved method based on high-resolution two-dimensional calibration of DNA sizes.

Feng YR, Norwood D, Shibata R, Gee D, Xiao X, Martin M, Zeichner SL, Dimitrov DS.

J Med Primatol. 1998 Oct;27(5):258-65.

PMID:
9926982
31.

Long-term telomere dynamics: modest increase of cell turnover in HIV-infected individuals followed for up to 14 years.

Feng YR, Biggar RJ, Gee D, Norwood D, Zeichner SL, Dimitrov DS.

Pathobiology. 1999;67(1):34-8.

PMID:
9873226
32.

Foscarnet.

Zeichner SL.

Pediatr Rev. 1998 Dec;19(12):399-400. No abstract available.

PMID:
9849068
33.
34.

The expression of the essential nuclear splicing factor SC35 is altered by human immunodeficiency virus infection.

Maldarelli F, Xiang C, Chamoun G, Zeichner SL.

Virus Res. 1998 Jan;53(1):39-51.

PMID:
9617768
35.

Tetracycline update.

Zeichner SL.

Pediatr Rev. 1998 Jan;19(1):32. No abstract available.

PMID:
9439167
36.

HIV-1 infection and the developing nervous system: lineage-specific regulation of viral gene expression and replication in distinct neuronal precursors.

Ensoli F, Wang H, Fiorelli V, Zeichner SL, De Cristofaro MR, Luzi G, Thiele CJ.

J Neurovirol. 1997 Aug;3(4):290-8. Review.

PMID:
9291237
37.

Umbilical Cord Blood Mononuclear Cell HIV-1 LTR Binding Activities.

Kedar PS, Arden K, Foyle M, Pope JH, Zeichner SL.

J Biomed Sci. 1997;4(5):217-228.

PMID:
12386383
38.

Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression.

Sorbara LR, Maldarelli F, Chamoun G, Schilling B, Chokekijcahi S, Staudt L, Mitsuya H, Simpson IA, Zeichner SL.

J Virol. 1996 Oct;70(10):7275-9.

39.

Kinetics of HIV-1 RNA concentration changes in pediatric patients.

Zeichner SL, Mueller BU, Pizzo PA, Dimitrov DS.

Pathobiology. 1996;64(6):289-94.

PMID:
9159022
40.

The molecular biology of HIV. Insights into pathogenesis and targets for therapy.

Zeichner SL.

Clin Perinatol. 1994 Mar;21(1):39-73. Review.

PMID:
8013186
42.
45.

Mechanisms and pathways of congenital infections.

Zeichner SL, Plotkin SA.

Clin Perinatol. 1988 Jun;15(2):163-88. Review.

PMID:
3288420
47.
49.

Attachment defect in mouse fibroblasts (L cells) persistently infected with Chlamydia psittaci.

Moulder JW, Levy NJ, Zeichner SL, Lee CK.

Infect Immun. 1981 Oct;34(1):285-91.

Supplemental Content

Loading ...
Support Center